Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation

American Journal of Cardiology

Volumn 103, Issue 2, 2009, Pages 227-231

  Lewis, William R ^a   Fonarow, Gregg C ^b   LaBresh, Kenneth A ^c   Cannon, Christopher P ^d   Pan, Wenqin ^e   Super, Dennis M ^a   Sorof, Suzanne A ^a   Schwamm, Lee H ^f  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MassPRO   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

AGED; ARTICLE; CONTROLLED STUDY; DRUG USE; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; STROKE; TELEMETRY; TOTAL QUALITY MANAGEMENT; TRANSIENT ISCHEMIC ATTACK;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; ELECTROCARDIOGRAPHY; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; RISK FACTORS; SECONDARY PREVENTION; STATISTICS, NONPARAMETRIC; STROKE; TREATMENT OUTCOME; WARFARIN;

EID: 58149467086     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.08.062     Document Type: Article

References (13)

1. Roe M.T. Success stories: how hospitals are improving care. Am Heart J 148 suppl (2004) S52-S55
2. LaBresh K.A., Reeves M.J., Frankel M.R., Albright D., and Schwamm L.H. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program. Arch Intern Med 168 (2008) 411-417
3. Hart R.G., Pearce L.A., Rothbart R.M., McAnulty J.H., Asinger R.W., and Halperin J.L. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 35 (2000) 183-187
4. Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagulation Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
5. Marcu C.B., Ghantous A.E., Caracciolo E.A., and Donohue T.J. Patterns of anticoagulation in patients hospitalized with atrial fibrillation: warfarin is underused in paroxysmal atrial fibrillation. Conn Med 67 (2003) 595-598
6. Friberg L., Hammar N., Ringh M., Pettersson H., and Rosenqvist M. Stroke prophylaxis in atrial fibrillation: who gets it and who does not?. Report from the Stockholm Cohort-Study on Atrial Fibrillation (SCAF-Study). Eur Heart J 27 (2006) 1954-1964
7. Barthélémy J.C., Feasson-Gerard S., Garnier P., Gaspoz J.M., Da Costa A., Michel D., and Roche F. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol 8 (2003) 194-199
8. Van Gelder I.C., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingma T., Said S.A., Darmanata J.I., Timmermans A.J., Tijssen J.G., and Crijns H.J. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
9. Wyse D.G., Waldo A.L., DiMarco J.P., Domanski M.J., Rosenberg Y., Schron E.B., Kellen J.C., Greene H.L., Mickel M.C., Dalquist J.E., and Corley S.D. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
10. Nieuwlaat R., Capucci A., Lip G.Y., Olsson S.B., Prins M.H., Nieman F.H., Lopez-Sendon J., Vardas P.E., Aliot E., Santini M., and Crijns H.J. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 27 (2006) 3018-3026
11. Lim M.J., Roychoudhury C., Baker P.L., Bossone E., and Mehta R.H. Differences in quality of care among patients hospitalized with atrial fibrillation as primary or secondary cause for admission. Int J Qual Health Care 17 (2005) 255-258
12. Choudhry N.K., Soumerai S.B., Normand S.L., Ross-Degnan D., Laupacis A., and Anderson G.M. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Am J Med 119 (2006) 607-615
13. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., and Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001) 2370-2375